Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 1Sarcoma 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Endometrial Adenocarcinoma 1Carcinoma, Medullary 1

Interventions

vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1nintedanib 1mercaptoundecahydrododecaborate 1Surveys and Questionnaires 1Docetaxel 14-boronophenylalanine-fructose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Thyroid Neoplasms × nintedanib × Clear all
NCT01788982 2020-07-31

Nintedanib(BIBF1120) in Thyroid Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
100 enrolled
Head & Neck

Thyroid Neoplasms, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡